EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mitochondrial dysfunction in schizophrenia and psychotic disorders: Implications for antipsychotic drug mechanisms

Svjetlana Loga-Zec, Aleksandra Klobučar, Orhan Lepara, Gorana Sulejmanpašić, Amra Memić-Serdarević, Nataša Loga-Andrijić

PSYCHIATRIA DANUBINA · 14.08.2026 · 38 (2) · 147-154

DOI: 10.24869/psyd.2026.147 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PSYCHIATRIA DANUBINA, online erschienen am 14.08.2026. Verfasst von Svjetlana Loga-Zec und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Mitochondria, Psychotic Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Schizophrenia (SCH) is a severe neuropsychiatric disorder associated with complex neurobiological alterations and suboptimal therapeutic outcomes. Increasing evidence indicates that mitochondrial dysfunction may contribute to SCH pathophysiology through impaired energy metabolism, oxidative stress, altered calcium homeostasis, and dysregulation of neuronal function. This review aims to summarize current knowledge regarding mitochondrial abnormalities in schizophrenia and to explore their potential involvement in the mechanisms of action of antipsychotic drugs. Subjects and Methods: A comprehensive review of the current literature was performed, focusing on human studies, cellular and animal models investigating mitochondrial alterations in schizophrenia, as well as studies evaluating the effects of antipsychotic medications on mitochondrial structure and function.

Results

Available evidence demonstrates structural, molecular, and functional mitochondrial abnormalities in schizophrenia, including alterations in mitochondrial density, respiratory chain activity, oxidative phosphorylation, ATP production, and redox regulation. Antipsychotic drugs influence mitochondrial pathways in a complex and drug-specific manner. Some antipsychotics may impair mitochondrial respiration and increase oxidative stress, whereas others may exert compensatory or protective effects. Mitochondrial alterations may also contribute to cognitive impairment, negative symptoms, treatment response variability, and metabolic adverse effects associated with antipsychotic therapy.

Conclusions

Mitochondrial dysfunction represents an important component of schizophrenia pathophysiology and a potential therapeutic target. The interaction between mitochondrial pathways and antipsychotic drug effects highlights mitochondria as a possible pharmacodynamic interface for personalized treatment strategies. Further in vivo studies and biomarker-based approaches are required to clarify drug–mitochondria interactions and improve therapeutic outcomes in schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaAntipsychotic AgentsMitochondriaPsychotic DisordersHumansOxidative StressAnimalsEnergy Metabolism

Stichwörter der Autor:innen

Schizophreniaantipsychotic drugsenergy metabolismmitochondrial dysfunctionoxidative stress

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Department of Pediatrics, Department of Child and Adolescent Psychiatry, Children's Hospital Zagreb, Zagreb, Croatia, University North, Croatia.
  • Department of Physiology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Department of Psychiatry, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Department of Neurology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Zitieren

APA

Loga-Zec, S., Klobučar, A., Lepara, O., Sulejmanpašić, G., Memić-Serdarević, A., & Loga-Andrijić, N. (2026). Mitochondrial dysfunction in schizophrenia and psychotic disorders: Implications for antipsychotic drug mechanisms. PSYCHIATRIA DANUBINA, 38(2), 147-154. https://doi.org/10.24869/psyd.2026.147

Vancouver

Loga-Zec S, Klobučar A, Lepara O, Sulejmanpašić G, Memić-Serdarević A, Loga-Andrijić N. Mitochondrial dysfunction in schizophrenia and psychotic disorders: Implications for antipsychotic drug mechanisms. PSYCHIATRIA DANUBINA. 2026;38(2):147-154. doi:10.24869/psyd.2026.147

BibTeX
@article{LogaZec2026,
  author = {Loga-Zec, Svjetlana and Klobučar, Aleksandra and Lepara, Orhan and Sulejmanpašić, Gorana and Memić-Serdarević, Amra and Loga-Andrijić, Nataša},
  title = {Mitochondrial dysfunction in schizophrenia and psychotic disorders: Implications for antipsychotic drug mechanisms},
  journal = {PSYCHIATRIA DANUBINA},
  year = {2026},
  volume = {38},
  number = {2},
  pages = {147--154},
  doi = {10.24869/psyd.2026.147}
}
Kostenlos starten →